ACE2 and cardiovascular disorder: Additionally, the use of drugs such as ACE-2 inhibitors and angiotensin receptor blockers (ARBs) in patients with hypertension and cardiovascular disease leads to ACE-2 overexpression in vivo, thereby increasing the risk of SARS-CoV-2 infection (25).